Clinical Trial Update: Treatment of Myelodysplastic Syndromes Comparing Hydralazine/Ac. Valproic and Supportive Care in Patients Not Candidates, Refractory and/or Intolerant to Intensive Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of hydralazine and valproic acid compared with supportive care in myelodysplastic syndrome patients not candid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Hydralazine (hydralazine)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Basque Health Service | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: UNKNOWN